Worrisome growth

Pediatric Endocrinology, Fifth Edition: Volume 2 Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders

Volumn , Issue , 2006, Pages 1-50

  Grimberg, Adda ^a   Lifshitz, Fima ^b,c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84983155518     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (480)

1. American Academy of Pediatrics Policy Statement-Committee on Practice and Ambulatory Medicine. Recommendations for preventive pediatric health care. Pediatrics 2000; 105:645.
2. Keyes R. The height of your life. Little Brown & Warner Books, 1980.
3. Hensley WE, Cooper R. Height and occupational success: a review and critique. Psychol Rep 1987; 60:843-849.
4. Hensley WE. Height as a measure of success in academe. Psychol J Hum Behav 1993; 30:40-46.
5. Kassarjian HH. Voting intentions and political perceptions. J Psychol 1963; 56:85-88.
6. Tuvemo T, Jonsson B, Persson I. Intellectual and physical performance and morbidity in relation to height in a cohort of 18-year-old Swedish conscripts. Horm Res 1999; 52:186-191.
7. Villimez C, Eisenberg N, Carroll JL. Sex differences in the relation of children’s height and weight to academic performance and others’ attributions of competence. Sex Roles 1986; 15:667-681.
8. Hensley WE. Height as a basis for interpersonal attraction. Adolescences 1994; 29:469-474.
9. Grimberg A, Kutikov JK, Cucchiara A. Sex differences in patients referred for evaluation of poor growth. J Pediatr 2005; 146:212-216.
10. Cuttler L, Silvers JB, Singh J, et al. Short stature and growth hormone therapy: a national study of physician recommendation patterns. J Am Med Assoc 1996; 276:531-537.
11. August GP, Lippe BM, Blethen SL, et al. Growth hormone treatment in the United States: demographic and diagnostic features of 2331 children. In: National Cooperative Growth Study (NCGS) Advisory Group, eds. Growth Hormone: Science, Research, and the Ncgs: 10 Years of Research. California, New Jercy: Gardiner-Caldwell Synermed, 1996:179-183.
12. Chatelain P. Trends in the diagnosis and treatment of short stature as revealed by KIGS. In: Ranke MB, Wilton P, eds. Growth Hormone Therapy in KIGS: 10 Years’ Experience. Heidelberg, Germany: Johann Ambrosius Barth Verlag, 1999:11-20.
13. Bolt LL, Mul D. Growth hormone in short children: beyond medicine? Acta Paediatr 2001; 90:69-73.
14. Sandberg DE, Colsman M, Voss LD. Short stature and quality of life: a review of assumptions and evidence. In: Pescovitz OH, Eugster E, eds. Pediatric Endocrinology: Mechanisms, Manifestations, and Management. Philadelphia: Lippincott, Williams Wilkins, 2004:191-202.
15. Sandberg DE, Colsman M. Assessment of psychosocial aspects of short stature. Growth Genet Horm 2005; 21:17-25.
16. Sandberg DE, Colsman M. Growth hormone treatment of short stature: status of the quality of life rationale. Horm Res 2005; 63:275-283.
17. Sandberg DE, Bukowski WM, Fung CM, Noll RB. Height and social adjustment: are extremes a cause for concern and action? Pediatrics 2004; 114:744-750.
18. Henwood M, Grimberg A, Moshang T Jr. The expanded spectrum of pediatric growth hormone use: evidence for growth benefits. Curr Opin Pediatr 2002; 14:437-442.
19. Macklin R. Growth hormone in short children: medically appropriate treatment. Acta Paediatr 2001; 90:5-6.
20. Kelnar CJ, Albertsson-Wikland K, Hintz RL, et al. Should we treat children with idiopathic short stature? Horm Res 1999; 52:150-157.
21. Haverkamp F, Ranke MB. The ethical dilemma of growth hormone treatment of short stature: a scientific theoretical approach. Horm Res 1999; 51:301-304.
22. American academy of pediatrics committee on drugs and committee on bioethics. Consideration related to the use of recombinant human growth hormone in children. Pediatrics 1997; 99:122-129.
23. White GB. Human growth hormone: the dilemma of expanded use in children. Kennedy Inst Ethics J 1993; 3:401-409.
24. Lantos J, Siegler M, Cuttler L. Ethical issues in growth hormone therapy. J Am Medic Assoc 1989; 261:1020-1024.
25. Bonamico M, Scire G, Mariani P, et al. Short stature as the primary manifestation of monosymptomatic celiac disease. J Pediatr Gastroenterol Nutr 1992; 14:12-16.
26. Kanof ME, Lake AM, Bayless TM. Decreased height velocity in children and adolescents before the diagnosis of crohn’s disease. Gastroenterology 1988; 95:1523-1527.
27. Giglio L, Candusso M, D’Orazio C, et al. Failure to thrive: the earliest feature of cystic fibrosis in infants diagnosed by neonatal screening. Acta Paediatr 1997; 86:1162-1165.
28. Roth KS, Chan JC. Renal tubular acidosis: a new look at an old problem. Clin Pediatr 2001; 40:533-543.
29. Arpadi SM. Growth failure in children with HIV infection. J AIDS 2000; 25(suppl 1):S37-S42.
30. Grimberg A, Cohen P. Optimizing growth hormone therapy in children. Horm Res 1997; 48(suppl 5):11-15.
31. Reiter EO, Blethen SL, Baptista J, et al. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner’s syndrome. J Clin Endocrinol Metab 2001; 86:1936-1941.
32. Lacey KA, Parkin JM. Causes of short stature. A community study of children in Newcastle-upon-Tyne. Lancet 1974; 1:42-45.
33. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994; 125:29-35.
34. Lifshitz F, Cervantes C. Short stature. In: Lifshitz F, ed. Pediatric Endocrinology. 3r ed. New York: Marcel Dekker, 1996:1-18.
35. Hebert PR, Rich-Edwards JW, Manson JE, et al. Height and incidence of cardiovascular disease in male physicians. Circulation 1993; 88:1437-1443.
36. Kannam JP, Levy D, Larson M, et al. Short stature and risk for mortality and cardiovascular disease events. The framingham heart study. Circulation 1994; 90:2241-2247.
37. Krahn AD, Manfreda J, Tate RB, et al. Evidence that height is an independent risk factor for coronary artery disease (the manitoba follow-up study). Am J Cardiol 1994; 74:398-399.
38. Colao A, Di Somma C, Vitale G, et al. Influence of growth hormone on cardiovascular health and disease. Treat Endocrinol 2003; 2:347-356.
39. Voss LD, Bailey BJR, Cumming K, et al. The reliability of height measurement (the Wessex growth study). Arch Dis Child 1990; 65:1340-1344.
40. Lipman TH, Hench K, Logan JD, et al. Assessment of growth by primary health care providers. J Pediatr Health Care 2000; 14:166-171.
41. Chen RS, Shiffman RN. Assessing growth patterns-routine but sometimes overlooked. Clin Pediatr 2000; 39: 97-102.
42. Tanner JM, Whitehouse RH, Marubini E, et al. The adolescent growth spurt of the boys and girls of the harpenden growth study. Ann Hum Biol 1976; 3:109-126.
43. Roche AF, Guo S, Baumgartner RM, et al. The measurement of stature. Am J Clin Nutr 1988; 47:922.
44. Voss LD, Bailey BJR. Equipping the community to measure children’s height: the reliability of portable instruments. Arch Dis Child 1994; 70:469-471.
45. Lipman TH, Hench KD, Benyi T, et al. A multicentre randomized controlled trial of an intervention to improve the accuracy of linear growth measurements. Arch Dis Child 2004; 89:342-346.
46. de Sanctis V. Manual of Growth Charts and Body Standard Measurements. 2nd ed. Pisa: Pacini Editore S.p.A., 2001.
47. Roberts SB, Dallal GE. The new childhood growth charts. Nutr Rev 2001; 59:31-36.
48. www.cdc.gov/growthcharts.
49. Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics 1998; 101:497-504.
50. Tanner JM. Normal growth and techniques of growth assessment. Clin Endocrinol Metab 1986; 15:411-451.
51. www.eurogrowth.org.
52. Haschke F, van’t Hof MA, The Euro-growth study group. Euro-growth references for length, weight, and body circumferences. J Pediatr Gastroenterol Nutr 2000; 31(suppl 1): S14-S38.
53. Van’t Hof MA, Haschke F, The Euro-growth study group. Euro-growth references for body mass index (BMI) and weight for length (WfL). J Pediatr Gastroenterol Nutr 2000; 31(suppl 1):S48-S59.
54. Van’t Hof MA, Haschke F, Darvay S, The Euro-growth study group. Euro-growth references on increments in length, weight, head, and arm circumference during the first three years of life. J Pediatr Gastroenterol Nutr 2000; 31(suppl 1):S39-S47.
55. Freeman V, Van’t Hof MA, Haschke F, The Euro-growthstudy group. Patterns of milk and food intake during the first three years of life. The Euro-Growth Study. J Pediatr Gastroenterol Nutr 2000; 31(suppl 1):S76-S85.
56. Haschke F, van’t Hof MA, The Euro-growth-study group. Euro-growth references for breastfed boys and girls: the influence of breastfeeding and solids on growth until 36 months of age. J Pediatr Gastroenterol Nutr 2000; 31(suppl 1):S60-S71.
57. Brook GGD, Hindmarsh PC, Healy MJR. A better way to detect growth failure. Br Med J 1986; 293:1186.
58. Lampl M, Veldhuis JD, Johnson ML. Saltation and stasis: a model of human growth. Science 1992; 258:801-803.
59. Wehr TA. Effect of seasonal changes in day length on human neuroendocrine function. Horm Res 1998; 49:118-124.
60. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity in British children. Arch Dis Child 1966; 41:613-616.
61. Tanner JM, Whitehouse RH. Clinical longitudinal standard for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51:170-171.
62. Pugliese MT, Lifshitz F, Grad G, et al. Fear of obesity: a cause of short stature and delayed puberty. N Engl J Med 1983; 309:513-518.
63. Lifshitz F, Moses N, Cervantes C, et al. Nutritional dwarfing in adolescence. Semin Adolesc Med 1987; 3:255-266.
64. Desai ID, Garcia-Tavares ML, Dutra de Oliveira BS, et al. Anthropometric and cycloergometric assessment of the nutritional status of the children of agricultural migrant workers in Southern Brazil. Am J Clin Nutr 1981; 34:1925-1934.
65. Trowbridge FL, Marks JS, Lopez de Romana G, et al. Body composition of Peruvian children with short stature and high weight-for-height: implications for the interpretation of weight-for-height as an indicator of nutritional status. Am J Clin Nutr 1987; 46:411-418.
66. Tanner JM, Goldstein H, Whitehouse RH. Standards for children’s height at ages 2-9 years allowing for heights of parents. Arch Dis Child 1970; 45:755-762.
67. Luo ZC, Albertsson-Wikland K, Karlberg J. Target height as predicted by parental heights in a population-based study. Pediatr Res 1998; 44:563-571.
68. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standard. J Pediatr 1952; 40:423-441.
69. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, CA: Stanford University Press, 1950.
70. Tanner JM, Whitehouse RH, Cameron N, et al. Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method). London: Academic Press, 1983.
71. Roche AF, Wainer H, Thissen D. The RWT method for the prediction of adult stature. Pediatrics 1975; 56:1026-1033.
72. Lenko HL. Prediction of adult height with various methods in Finnish children. Acta Pediatr Scand 1979; 68:85-92.
73. Cox LA. The biology of bone maturation and ageing. Acta Paediatr Suppl 1997; 423:107-108.
74. Roche AF, Davila GH, Leyman SL. A comparison between Greulich-Pyle and Tanner-Whitehouse assessment of skeletal maturity. Radiol 1971; 98:273-280.
75. Hall JG, Froster-Iskenius U, Allanson J. Handbook of normal physical measurements. Oxford, UK: Oxford University Press, 1989.
76. Albanses A, Stanhope R. Does constitutional delayed puberty cause segmental disproportion and short stature? Eur J Pediatr 1993; 152:293-296.
77. Cervantes C, Lifshitz F. Tubular bone alterations in familial short stature. Hum Biol 1988; 60:151-165.
78. Hagenas L, Hertel T. Skeletal dysplasia, growth hormone treatment, and body proportion: comparison with other syndromic and non-syndromic short children. Horm Res 2003; 60(suppl 3):65-70.
79. Moshang T Jr., Grimberg A. The effects of irradiation and chemotherapy on growth. Endocrinol Metab Clin N Am 1996; 25:731-741.
80. Markowitz RI, Zackai E. A pragmatic approach to the radiologic diagnosis of pediatric syndromes and skeletal dysplasias. Radiol Clin N Am 2001; 39: 791-802.
81. Vanhoenacker FM, De Schepper AM, Parizel PM. Congenital abnormalities of the osseous spine: a radiological approach. JBR-BTR 2005; 88:37-41.
82. Goncalves LF, Espinoza J, Mazor M, et al. Newer imaging modalities in the prenatal diagnosis of skeletal dysplasias. Ultrasound Obstet Gynecol 2004; 24:115-120.
83. Mortier GR. The diagnosis of skeletal dysplasias: a multidisciplinary approach. Eur J Radiol 2001; 40: 161-167.
84. Superti-Furga A, Bonafe L, Rimoin DL. Molecular-pathogenetic classification of genetic disorders of the skeleton. Am J Med Genet 2001; 106:282-293.
85. Savarirayan R, Rimoin DL. The skeletal dysplasias. Best Pract Res Clin Endocrinol Metab 2002; 16:547-560.
86. Sybert VP, McCauley E. Turner’s syndrome. N Engl J Med 2004; 351:1227-1238.
87. Wilson LC, Hall CM. Albright’s hereditary osteodystrophy and pseudohypoparathyroidism. Semin Musculoskelet Radiol 2002; 6:273-283.
88. Cervantes CD, Lifshitz F, Levenbrown J. Radiologic anthropometry of the hand in patients with familial short stature. Pediatr Radiol 1988; 18:210-214.
89. Rao E, Weiss B, Fukami M, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997; 16:54-63.
90. Ross JL, Scott C Jr., Marttila P, et al. Phenotypes associated with SHOX deficiency. J Clin Endocrinol Metab 2001; 86:5674-5680.
91. Ogata T. SHOX haploinsufficiency and its modifying factors. J Pediatr Endocrinol Metab 2002; 15(suppl 5):1289-1294.
92. Musebeck J, Mohnike K, Beye P, et al. Short stature homeobox-containing gene deletion screening by fluorescence in situ hybridisation in patients with short stature. Eur J Pediatr 2001; 160:561-565.
93. www.esoterix.com.
94. Jones KL. Smith’s Recognizable Patterns of Human Malformations. 6th ed. Philadelphia: Elsevier Saunders, 2006.
95. Stewart RE, Horton WA, Eteson DJ. General concepts of growth and development. In: Stewart RE, Barber TK, Troutman KC, Wei SHY, eds. Pediatric Dentistry: Scientific Foundations and Clinical Practice. St. Louis: CV Mosby, 1982:3-34.
96. Duterloo HS. An Atlas of Dentition in Childhood. London: Wolfe Publishing, 1991:93-96.
97. Lifshitz F, Tarim O. Worrisome growth patterns in children. Int Pediatr 1994; 9:181-188.
98. Sedlmeyer IL, Hirschhorn JN, Palmert MR. Pedigree analysis of constitutional delay of growth and maturation: determination of familial aggregation and inheritance patterns. J Clin Endocrinol Metab 2002; 87:5581-5586.
99. Horner JM, Thorsson AV, Hinz RI. Growth deceleration patterns in children with constitutional short stature: an aid to diagnosis. Pediatr 1978; 62:529-534.
100. Vaquero-Solans C, Lifshitz F. Body weight progression and nutritional status of patients with familial short stature with and without constitutional delay in growth. Am J Dis Child 1991; 146:296-302.
101. Galler JR, Ramsey F, Solimano G. A follow-up study of the effects of early malnutrition in subsequent development in physical growth and sexual maturation during adolescence. Pediatr Res 1985; 19:518-523.
102. Harel Z, Tannenbaum GS. Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat. Pediatr Res 1995; 38:747-753.
103. Sisk CL, Foster DL. The neural basis of puberty and adolescence. Nat Neurosci 2004; 7:1040-1047.
104. Cunningham MJ, Clifton DK, Steiner RA. Leptin’s actions on the reproductive axis: perspectives and mechanisms. Biol Reprod 1999; 60:216-222.
105. Swerdloff RS, Batt RA, Bray GA. Reproductive hormonal function in the genetically obese (ob/ob) mouse. Endocrinol 1976; 98:1359-1364.
106. Strobel A, Issad T, Camoin L, et al. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998; 18:213-215.
107. Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996; 12:318-320.
108. Cheung CC, Thornton JE, Kuijper JL, et al. Leptin is a metabolic gate for the onset of puberty in the female rat. Endocrinology 1997; 138:855-858.
109. Cunningham MJ. Galanin-like peptide as a link between metabolism and reproduction. J Neuroendocrinol 2004; 16:717-723.
110. Barreiro ML, Tena-Sempere M. Ghrelin and reproduction: a novel signal linking energy status and fertility? Molec Cell Endocrinol 2004; 226:1-9.
111. Castellano JM, Navarro VM, Fernández-Fernández R, et al. Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. Endocrinology 2005; 146:3917-3925.
112. Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003; 349:1614-1627.
113. de Roux N, Genin E, Carel JC, et al. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 2003; 100:10972-10976.
114. Semple RK, Achermann JC, Ellery J, et al. Two novel missense mutations in G protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2005; 90:1849-1855.
115. Bideci A, Cinaz P, Hasanoglu A, et al. Leptin, insulin-like growth factor (IGF)-I and IGF binding protein-3 levels in children with constitutional delay of growth. J Pediatr Endocrinol Metab 2002; 15:41-46.
116. Palmert MR, Boepple PA. Variation in the timing of puberty: clinical spectrum and genetic investigation. J Clin Endocrinol Metab 2001; 86:2364-2368.
117. Sedlmeyer IL, Pearce CL, Trueman JA, et al. Determination of sequence variation and haplotype structure for the gonadotropin-releasing hormone (GnRH) and GnRH receptor genes: investigation of role in pubertal timing. J Clin Endocrinol Metab 2005; 90:1091-1099.
118. LaFranchi S, Hanna CE, Mandel SH. Constitutional delay of growth: expected versus final adult height. Pediatrics 1991; 87:82-87.
119. Crowne EC, Shalet SM, Wallace WHB, et al. Final height in boys with untreated constitutional growth delay in growth and puberty. Arch Dis Child 1990; 65:1109-1112.
120. Hagg U, Taranger J. Pubertal growth and maturity pattern in early and late maturers. A prospective longitudinal study of Swedish urban children. Swed Dent J 1992; 16:199-209.
121. Hintz RL. Final height prediction in constitutional growth delay. J Pediatr Endocrinol Metab 2001; 14(suppl 6): 1535-1540.
122. Rosenfeld RG, Northcraft GB, Hintz RL. A prospective, randomized study of testosterone treatment of constitutional delay of growth and development in male adolescents. Pediatrics 1982; 69:681-687.
123. Bierich JR. Constitutional delay of growth and adolescence. Baillieres Clin Endocrinol Metab 1992; 6: 573-588.
124. Blizzard RM, Hindmarsh PC, Stanhope R. Oxandrolone therapy: 25 years experience. Growth Genet Horm 1991; 4:1-6.
125. Finkelstein JS, Klibanski A, Neer R. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab 1996; 81:1152-1155.
126. Binder G, Schwartz CP, Ranke MB. Identification of short stature by SHOX defects and therapeutic effects of recombinant human growth hormone. J Clin Endocrinol Metab 2000; 85:245-249.
127. Rappold GA, Fukami M, Neisler B, et al. Deletions of the homeobox gene SHOX (Short Stature Homeobox) are important cause of growth failure in children with short stature. J Clin Endocrinol Metab 2002; 87:1402-1406.
128. Ogata T, Matsuo N, Nishimura G. SHOX haploinsufficiency and overdosage: impact of gonadal function status. J Med Genet 2001; 38:1-6.
129. Beresma D. The National Foundation March Of Dimes. In: Birth defects compendium. 2nd ed. New York: Alan R. Liss, 1982:151-152.
130. Hall B, Spranger J. Hypochondroplasia: clinical and radiological aspects in 39 cases. Radiology 1979; 133: 95-100.
131. Gebhardt-Henrich SG. Heritability of growth curve parameters and heritability of final size: a simulation study. Growth Dev Aging 1992; 56:23-34.
132. Mullis PE, Deladoey J, Dannies PS. New GH-1 gene mutations: expanding the spectrum of causes of isolated growth hormone deficiency. J Pediatr Endocrinol Metab 2002; 15(suppl 5):1301-1310.
133. Attie KM. Genetic studies in idiopathic short stature. Curr Opin Pediatr 2000; 12:400-404.
134. Hintz RL, Attie KM, Baptista J, et al. Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genetech collaborative group. N Engl J Med 1999; 340:502-507.
135. Leschek EW, Rose SR, Yanovski JA, et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2004; 89:3140-3148.
136. Grimberg A, De Leon D. Disorders of growth. In: Moshang T Jr., ed. Pediatr Endocrinol: The requisites in Pediatrics. Philadelphia: Elsevier, Inc., 2005: 127-167.
137. Savendahl L, Davenport ML. Delayed diagnoses of Turner’s syndrome: proposed guidelines for change. J Pediatr 2000; 137:455-459.
138. Soriano-Guillen L, Coste J, Ecosse E, et al. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. J Clin Endocrinol Metab 2005; 90:5197-5204.
139. Cronk C, Crocker AC, Pueschel SM, et al. Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics 1988; 81:102-110.
140. Torrado C, Bastian W, Wisniewski KE, et al. Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone. J Pediatr 1991; 119:478-483.
141. Anneren G, Tuvemo T, Gustafsson J. Growth hormone therapy in young children with Down syndrome and a clinical comparison of Down and Prader-Willi syndromes. Growth Horm IGF Res 2000; 10(suppl B):S87-S91.
142. Kodish E, Cuttler L. Ethical issues in emerging new treatments such as growth hormone therapy for children with Down syndrome and Prader-Willi syndrome. Curr Opin Pediatr 1996; 8:401-405.
143. Goldstone AP. Prader-Willi syndrome: advances in genetics, pathophysiology, and treatment. Trends Endocrinol Metab 2004; 15:12-20.
144. Allen DB, Carrel AL. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal. J Pediatr Endocrinol Metab 2004; 17(suppl 4):1297-1306.
145. Eiholzer U. Deaths in children with Prader-Willi syndrome: a contribution to the debate about the safety of growth hormone treatment in children with PWS. Horm Res 2005; 63:33-39.
146. Nagai T, Obata K, Tonoki H, et al. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A 2005; 136:45-48.
147. Schrander-Stumpel CT, Curfs LM, Sastrowijoto P, et al. Prader-Willi syndrome: causes of death in an international series of 27 cases. Am J Med Genet A 2004; 124:333-338.
148. Eiholzer U, Whitman BY. A comprehensive team approach to the management of patients with Prader-Willi syndrome. J Pediatr Endocrinol Metab 2004; 17:1153-1175.
149. Rimoin DL. International nomenclature and classification of the osteochondrodysplasias: international working group on constitutional diseases of bone. Am J Med Genet 1998; 79:376-382.
150. Stanhope R, Albanese A, Azcona C. Growth hormone treatment of Russell-Silver syndrome. Horm Res 1998; 49(suppl 2):37-40.
151. Schwartz ID, Schwarts KJ, Kouseff BG, et al. Endocrinopathies in cornelia de lange syndrome. J Pediatr 1990; 117:920-922.
152. Gillis LA, McCallum J, Kaur M, et al. NIPBL mutational analysis in 120 individuals with Cornelia de Lange syndrome and evaluation of genotype-phenotype correlations. Am J Hum Genet 2004; 75:610-623.
153. Gershoni-Baruch R, Lerner A, Braun J, et al. Johanson-Blizzard syndrome: clinical spectrum and further delineation of the syndrome. Am J Med Genet 1990; 35:546-551.
154. Shanske A, Caride DG, Menasse-Palmer L, et al. Central nervous system anomalies in Seckel syndrome: report of a new family and review of the literature. Am J Med Genet 1997; 70:155-158.
155. Morris CA, Mervis CB.Williams syndrome and related disorders. Annu Rev Genomics Hum Genet 2000; 1:461-484.
156. Kaplan P, Wang PP, Francke U. Williams (Williams Beuren) syndrome: a distinct neurobehavioral disorder. J Child Neurol 2001; 16:177-190.
157. Bamberg C, Kalache KD. Prenatal diagnosis of fetal growth restriction. Semin Fetal Neonatal Med 2004; 9:387-394.
158. Hediger MI, Overpeck MD, Maurer KR, et al. Growth of infants and young children born small or large for gestational age: findings from the third national health and nutrition examination survey. Arch Pediatr Adolesc Med 1998; 152:1225-1231.
159. Albertsson-Wikland K, Karlberg J. Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Suppl 1994; 399:64-70.
160. McCormick M. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985; 312:82-90.
161. McIntire DD, Bloom SL, Casey BM, et al. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340:1234-1238.
162. Goldberg RL, Cutter GR, Hoffman HJ, et al. Intrauterine growth retardation: standards for diagnosis. Am J Obstet Gynecol 1989; 161:271-277.
163. Usher R, McLean F. Intrauterine growth of live born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. Pediatrics 1969; 74:901-910.
164. Brenner WE, Edelman DA, Hendricks CH. A standard for fetal growth for the United States of America. Am J Obstet Gynecol 1976; 126:555-564.
165. Seeds JW, Peng T. Impaired growth and risk of fetal death: is the tenth percentile the appropriate standard? Am J Obstet Gynecol 1998; 178:658-667.
166. Chang TC, Robson SC, Boys RJ, et al. Prediction of the small for gestational age infant: which ultrasonic measurement is best? Obstet Gynecol 1992; 80:1030-1038.
167. Harkness UF, Mari G. Diagnosis and management of intrauterine growth restriction. Clin Perinatol 2004; 31:743-764.
168. Bahado-Singh R, Oz U, Kovanchi E, et al. Mid-trimester maternal uterine marker for the prediction of subsequent IUGR. Am J Obstet Gynecol 1999; 180(suppl II):174-175.
169. Haggarty P, Campbell DM, Bendomir A, et al. Ponderal index is a poor predictor of in utero growth retardation. Br J Obstet Gynecol 2004; 111:113-119.
170. Baschat AA. Pathophysiology of fetal growth restriction: implications for diagnosis and surveillance. Obstet Gynecol Surv 2004; 59:617-627.
171. Klebanoff MA, Mairik O, Berendes HW. Second generation consequences of small-for-dates birth. Pediatrics 1989; 84:343-347.
172. Godfrey K, Robinson S, Barker DJP, et al. Maternal nutrition in early and late pregnancy in relation to placental and fetal growth. Br Med J 1996; 312:410-414.
173. Luke S, Gillespie B, Min S-J, et al. Critical periods of maternal weight gain: effect on twin birth weight. Am J Obstet Gynecol 1997; 177:1055-1062.
174. Baschat AA, Gembruch U, Harman CR. The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet Gynecol 2001; 18:571-577.
175. Abrams B, Selvin S. Maternal weight gain pattern and birth weight. Obstet Gynecol 1995; 86:163-169.
176. Food and Nutrition Board, Institute of Medicine (United States). Nutrition During Pregnancy And Lactation. Washington: National Academy Press, 1990:1-233.
177. American College of Obstetricians and Gynecologists. Nutrition During Pregnancy. Am Col Obstet Gynecol (Washington) 1993; [Technical bulletin no. 179].
178. Brown HL, Watkings K, Hiett KA. Fetus-placenta-newborn; the impact of the women, infants and children food supplement program on birth outcome. Am J Obstet Gynecol 1996; 174:279-283.
179. Scholl TO. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr 2005; 81:S1218-S1222.
180. Relton CL, Pearce MS, Parker L. The influence of erythrocyte folate and serum vitamin B12 status on birth weight. Br J Nutr 2005; 93:593-599.
181. Gluckman PD, Hanson MA. Maternal constraint of fetal growth and its consequences. Semin Fetal Neonatal Med 2004; 9:419-425.
182. Kleijer ME, Dekker GA, Heard AR. Risk factors for intrauterine growth restriction in a socio-economically disadvantaged region. J Matern Fetal Neonatal Med 2005; 18:23-30.
183. Hammoud AO, Bujold E, Sorokin Y, et al. Smoking in pregnancy revisited: findings from a large population-based study. Am J Obstet Gynecol 2005; 192:1856-1862.
184. Torres-Arreola LP, Constantino-Casas P, Flores-Hernandez S, et al. Socioeconomic factors and low birth weight in Mexico. BMC Public Health 2005; 5:20.
185. Sram RJ, Binkova B, Dejmek J, et al. Ambient air pollution and pregnancy outcomes: a review of the literature. Environ Health Perspect 2005; 113:375-382.
186. Nahum GG, Stanislaw H. Hemoglobin, altitude and birth weight: does maternal anemia during pregnancy influence fetal growth? J Reprod Med 2004; 49:297-305.
187. Stegmann BJ, Carey JC. TORCH infections, toxoplasmosis, other (syphilis, varicella-zoster, parvovirus B19), rubella, cytomegalovirus (CMV), and herpes infections. Curr Womens Health Rep 2002; 2:253-258.
188. Berge P, Stagno S, Federer W, et al. Impact of asymptomatic congenital cytomegalovirus infection on size at birth and gestational duration. Pediatr Infect Dis J 1990; 9:170-175.
189. Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1998; 105:836-848.
190. Monk D, Moore GE. Intrauterine growth restriction-genetic causes and consequences. Semin Fetal Neonatal Med 2004; 9:371-378.
191. Butler MG. Imprinting disorders: non-Mendelian mechanisms affecting growth. J Pediatr Endocrinol Metab 2002; 15(suppl 5):1279-1288.
192. Yoshihashi H, Maeyama K, Kosaki R, et al. Imprinting of human GRB10 and its mutations in two patients with Russell-Silver syndrome. Am J Hum Genet 2000; 67:476-482.
193. Krook A, Brueton L, O’Rahilly S. Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism. Lancet 1993; 342:227-228.
194. Bersinger NA, Odegard RA. Second-and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies. Acta Obstet Gynecol Scand 2004; 83:37-45.
195. Sorensen S, von Tabouillot D, Schioler V, et al. Serial measurements of serum human placental lactogen (hPL) and serial ultrasound examinations in the evaluation of fetal growth. Early Hum Dev 2000; 60:25-34.
196. Gardner MO, Goldenberg RL, Cliver SP, et al. Maternal serum concentrations of human placental lactogen, estradiol and pregnancy specific beta 1-glycoprotein and fetal growth retardation. Acta Obstet Gynecol Scand Suppl 1997; 165:56-58.
197. Leger J, Noel M, Limal JM, Czernichow P. Growth factors and intrauterine growth retardation II. Serum growth hormone, insulin-like growth factor (IGF)-1 and IGF binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Pediatr Res 1996; 40:101-107.
198. Cance-Rouzaud A, Laborie S, Bieth E, et al. Growth hormone, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are regulated differently in small-for-gestational-age and appropriate-for-gestational-age neonates. Biol Neonate 1998; 73:347-355.
199. Job JC, Chatelain P, Rochiccioli P, et al. Growth hormone response to a bolus injection of 1-44 growth-hormonereleasing hormones in very short children with intrauterine onset growth failure. Horm Res 1990; 33:161-165.
200. Ali O, Cohen P. Insulin-like growth factors and their binding proteins in children born small for gestational age: implication for growth hormone therapy. Horm Res 2003; 60(suppl 3):115-123.
201. Accili D, Nakae J, Kim JJ, et al. Targeted gene mutations define the roles of insulin and IGF-I receptors in mouse embryonic development. J Pediatr Endocrinol Metab 1999; 12:475-485.
202. Woods KA, Camacho-Hubner C, Savage MO, et al. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996; 335:1363-1367.
203. Abuzzahab MJ, Schneider A, Goddard A, et al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003; 349:2211-2222.
204. Kofoed EM, Hwa V, Little B, et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003; 349:1139-1147.
205. Laron Z. The essential role of IGF-I: lessons from the longterm study and treatment of children and adults with Laron syndrome. J Clin Endocrinol Metab 1999; 84:4397-4404.
206. Laviola L, Perrini S, Belsanti G, et al. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology 2005; 146:1498-1505.
207. Grimberg A, Katz JL. Hypothalamus: neuroendometabolic center. In: Polin R, Fox WW, Abman SH, eds. Fetal and Neonatal Physiology3rd. Orlando: Elsevier science, 2003:1871-1880.
208. Jaquet D, Leger J, Levy-Marchal C, et al. Ontogeny of leptin in human fetuses and newborns effect of intrauterine growth retardation on serum leptin concentrations. J Clin Endocrinol Metab 1998; 83:243-246.
209. Marchini G, Fried G, Ostlund E, et al. Plasma leptin in infants: relations to birth weight and weight loss. Pediatrics 1998; 101:429-432.
210. Peralta-Carcelen M, Jackson DS, Goran MI, et al. Growth of adolescents who were born at extremely low birth weight without major disability. J Pediatr 2000; 136: 633-640.
211. Strauss RS, Dietz WH. Growth and development of term children born with low birth weight: effects of genetic and environmental factors. J Pediatr 1998; 133:67-72.
212. Kelleher KJ, Casey PH, Bradley RH, et al. Risk factors and outcomes for failure to thrive in low birth weight preterm infants. Pediatrics 1993; 91:941-948.
213. vanWeissenbruch MM, Engelbregt MJ, Veening MA, et al. Fetal nutrition and timing of puberty. Endocr Dev 2005; 8:15-33.
214. Reilley SM, Skuse DH, Wolke D, et al. Oral-motor dysfunction in children who fail to thrive: organic or non-organic? Dev Med Child Neurol 1999; 41:115-122.
215. Embleton NE, Pang N, Cook RJ. Postnatal malnutrition and growth retardation: an inevitable consequence of current recommendations in preterm infants? Pediatrics 2001; 107:270-273.
216. Chernausek SD. Growth hormone treatment of short children born small for gestational age: a U.S perspective. Horm Res 2004; 62(suppl 3):124-127.
217. Hokken-Koelega AC, van Pareren Y, Sas T, et al. Final height data, body composition, and glucose metabolism in growth hormone-treated short children born small for gestational age. Horm Res 2003; 60(suppl 3):113-114.
218. Dahlgren J, Wikland KA. Swedish study group for growth hormone treatment. Final height in short children born small for gestational age treated with growth hormone. Pediatr Res 2005; 57:216-222.
219. Ranke MB, Lindberg A. Growth hormone treatment of short children born small for gestational age or with Silver-Russell syndrome: results from KIGS (kabi international growth study), including the first report on final height. Acta Paediatr Suppl 1996; 417:18-26.
220. Barker DJP, Gluckman PD, Godfrey KM, et al. Fetal nutrition and cardiovascular diseases in adult life. Lancet 1993; 341:938-941.
221. Williams S, St.George IM, Silva PA. Intrauterine growth retardation and blood pressure at age seven and eighteen. J Clin Epidemiol 1992; 45:1257-1263.
222. Leger J, Levy-Marchal C, Bloch J, et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. Br Med J 1997; 315:341-347.
223. Laor A, Stevenson DK, Shemer JG, et al. Size at birth: maternal nutritional status in pregnancy and blood pressure at age 17. Br Med J 1997; 315:449-453.
224. Rich-Edwards JW, Colditz GA, Stampfer MJ, et al. Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med 1999; 130:278-284.
225. Litheil HO, McKeigue PM, Berglund L, et al. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. Br Med J 1996; 312:406-410.
226. Hofman PL, Cutfield WS, Robinson EM, et al. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997; 82:402-406.
227. Barker DJP, Gluckman PD, Robinson JS. Fetal origins of adult disease: report of the first study group (Sydney, 29-30 October, 1994). Placenta 1995; 16:317-320.
228. Hales CN, Barker DJ. Type 2 (non-insulin dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35:444-446.
229. Simmons R. Developmental origins of adult metabolic disease: concepts and controversies. Trends Endocrinol Metab 2005; 16:390-394.
230. Barker DJP, Osmond C, Forsén TJ, et al. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005; 353:1802-1809.
231. Yanney M, Marlow N. Paediatric consequences of fetal growth restriction. Semin Fetal Neonatal Med 2004; 9:411-418.
232. Shah MD. Failure to thrive in children. J Clin Gastroenterol 2002; 35:371-374.
233. Porter B, Skuse D. When does slow weight gain become ‘failure to thrive’? Arch Dis Child 1991; 66:905-906.
234. Mitchell WG, Gorrell RW, Greenberg RA. Failure-tothrive: a study in a primary care setting epidemiology and follow-up. Pediatrics 1980; 65:971-977.
235. WilcoxWD, NieburgP, MillerDS. Failure to thrive: a continuing problem of definition. Clin Pediatr 1989; 28:391-394.
236. Rosenn DW, Loeb LS, Jura MB. Differentiation of organic from non-organic failure to thrive syndrome in infancy. Pediatrics 1980; 66:698-704.
237. Frank DA, Zeisel SH. Failure to thrive. Ped Clin N Am 1988; 35:1187-1200.
238. Frank DA, Zeisel SH. Failure to thrive: mystery, myth, and method. Contemp Pediatr 1993; 2:114.
239. Edwards AGK, Halse PC, Parkin JM, Waterson AJ. Recognizing failure to thrive in early childhood. Arch Dis Child 1990; 65:1263-1265.
240. Skuse DH. Non-organic failure to thrive: a reappraisal. Arch Dis Child 1985; 60:173-178.
241. Krugman SD, Dubowitz H. Failure to thrive. Am Fam Physician 2003; 68:879-884.
242. Lifshitz JZ, Lifshitz F. Failure to thrive. In: Lifschitz CL, ed. Pediatric Gastroenterology and Nutrition. New York: Marcel Dekker, 2001:301-326.
243. Sheard NF. Growth patterns in the first year of life: what is the norm? Nutr Rev 1993; 51:52-54.
244. Salmenpera L, Peerheentupa J, Slimes MA. Exclusively breast-fed healthy infants grow slower than reference infants. Pediatr Res 1985; 19:307-312.
245. World Health Organization. Growth patterns of breastfed infants in seven countries WHO working group on the growth reference protocol and WHO task force on methods for the natural regulation of fertility. Acta Paediatr 2000; 89:215-222.
246. Lonnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr 2003; 77:S1537-S1543.
247. Kramer MS, Kakuma R. The optimal duration of exclusive breastfeeding: a systematic review. Adv Exp Med Biol 2004; 554:63-77.
248. Pediatric Nutrition Handbook. Elk Grove Village Ill: AAP, 2003:57.
249. Powers NG. How to assess slow growth in the breastfed infant; birth to 3 months. Pediatr Clin N Am 2001; 48:345-363.
250. Dewey KG, Heining MJ, Nommsen LA, Peerson JM, Lonnerdal B. Growth of breast-fed infants from 0 to 19 months: the DARLING Study. Pediatrics 1992; 89: 1035-1041.
251. Dewey KG. Nutrition, growth, and complementary feeding of the breastfed infant. Pediatr Clin N Am 2001; 48: 87-104.
252. Wilensky DS, Ginsberg G, Altman M, Tullchinsky TH, Ben Yishay F, Auerbach JA. A community-based study of failure to thrive in Israel. Arch Dis Child 1996; 75: 145-148.
253. Altemeier WA, O’Connor SM, Sherrod KB, Vietze PM. Prospective study of antecedents of nonorganic failure to thrive. J Pediatr 1985; 106:360-365.
254. Block RW, Krebs NF. The American Academy of Pediatrics Committees on child abuse and neglect and nutrition. Failure to thrive as a manifestation of child neglect. Pediatrics 2005; 116:1234-1237.
255. Steward DK. Behavioral characteristics of infants with nonorganic failure to thrive during a play interaction. Am J Matern Child Nurs 2001; 26:79-85.
256. Dusick A. Investigation and management of dysphagia. Semin Pediatr Neurol 2003; 10:255-264.
257. Frank DA, Wong F. Effects of prenatal exposures to alcohol, tobacco, and other drugs. In: Kessler DB, Dawson P, eds. Failure to Thrive and Pediatric Undernutrition-A Transdisciplinary Approach. Baltimore: Brookes publishing co., 1999:275-280.
258. Pugliese MT, Weyman-Daum M, Moses N, Lifshitz F. Parental health beliefs as a cause of non-organic failure to thrive. Pediatrics 1987; 80:175-182.
259. Lifshitz F. Children on adult diets Is it harmful? Is it healthful? J Am Coll Nutr 1992; 11:845-905.
260. McCann JB, Stein A, Fairburn CG, Dunger DB. Eating habits and attitudes of mothers of children with nonorganic failure to thrive. Arch Dis Child 1994; 70:234-236.
261. Lifshitz F, Tarim O. Nutritional dwarfing. Curr Prob Pediatr 1993; 23:322-326.
262. Smith MM, Lifshitz F. Excessive fruit juice consumption as a contributing factor in non-organic failure to thrive. Pediatrics 1993; 93:438-443.
263. Campbell M, Lofters WS, Gibbs W. Rastafarianism and the vegan syndrome. Br Med J 1982; 285:1617-1618.
264. Roberts IF, West RJ, Ogilvie D, Dillon MJ. Malnutrition in infants receiving cult diets: a form of child abuse. Br Med J 1979; 1:296-298.
265. Sanders TA, Reddy S. Vegetarian diets and children. Am J Clin Nutr 1994; 59(5 suppl):S1176-S1181.
266. Branca F, Ferrari M. Impact of micronutrient deficiencies on growth: the stunting syndrome. Ann Nutr Metab 2002; 46(suppl 1):8-17.
267. Doherty CP, Crofton PM, Sarkar MA, et al. Malnutrition, zinc supplementation and catch-up growth: changes in insulin-like growth factor I, its binding proteins, bone formation, and collagen turnover. Clin Endorinol 2002; 57:391-399.
268. Martorell R. Results and implications of the INCAP follow-up study. J Nutr 1995; 125:S1127-S1138.
269. Caulfield LE, Himes JH, Rivera JA. Nutritional supplementation during early childhood and bone mineralization during adolescence. J Nutr 1995; 125:S1104-S1110.
270. Di Lorenzo C, Benninga MA, Forbes D, et al. N Am Soc Pediatr GastroentHepatolNutri. Functional gastrointestinal disorders, gastroesophageal reflux, and neurogastroenterology: working group report of the second world congress of pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr 2004; 39(suppl 2):S616-S625.
271. Vandenplas Y, Lifshitz JZ, Orenstein S, et al. Nutritional management of regurgitation in infants. J Am Coll Nutr 1998; 17:308-316.
272. Ramsay M, Gisel EG, Boutry M. Non-organic failure to thrive: growth failure secondary to feeding-skills disorder. Dev Med Child Neurol 1993; 35:285-297.
273. Dobbing J. Vulnerable periods in developing brain. In: Dobbing J, ed. Brain, Behavior and Iron in the Infant Diet. New York: Springer-Verlag, 1990.
274. Wachs TD. Relation of mild-to-moderate malnutrition to human development: correlational studies. J Nutr 1995; 125(suppl 8):S2245-S2254.
275. Idjradinata P, Pollitt E. Reversal of developmental delays in iron-deficient anemic infants treated with iron. Lancet 1993; 341:1-4.
276. Pollitt E, Oh S. Early supplementary feeding, child development and health policy. Food Nutr Bull 1994; 15:208-214.
277. Oken E, Duggan C. Update on micronutrients: iron and zinc. Curr Opin Pediatr 2002; 14:350-353.
278. Bithoney WG. Elevated lead levels in children with nonorganic failure to thrive. Pediatrics 1986; 78:891-895.
279. Carlson EA, Sampson MC, Sroufe LA. Implications of attachment theory and research for developmental-behavioral pediatrics. J Dev Behav Pediatr 2003; 24:364-379.
280. Lifshitz F, Moses-Finch N, Lifshitz JZ. Failure to thrive. In: Children’s Nutrition. Boston: Jones & Bartlett, 1991:253-270.
281. Krieger I. Food restriction as a form of child abuse in 10 cases of psychosocial deprivation dwarfism. Clin Pediatr 1974; 13:127-133.
282. Whitten C, Fischoff J. Evidence that growth failure from maternal deprivation is secondary to undereating. J Am Med Assoc 1969; 209:1675-1682.
283. Krieger I. Endocrines and nutrition in psychosocial deprivation in the USA: comparison with growth failure due to malnutrition on an organic basis. In: Gardner LI, Amacher P, eds. Endocrine Aspects of Malnutrition: Marasmus, Kwashiorkor, and Psychosocial Deprivation. Santa Ynez, CA: Kroc Foundation, 1973:129-162.
284. Gardner LI. Deprivation dwarfism. Sci Am 1972; 227: 76-82.
285. Green WH. Psychosocial dwarfism: psychological and etiological considerations. Adv Clin Child Psychol 1986; 9:245-278.
286. Bakwin H. Loneliness in infants. Am J Dis Child 1942; 62:30-40.
287. Talbot NB, Sobel EH, Burke BS, Lindemann E, Kaufman SB. Dwarfism in healthy children, its possible relation to emotional, nutritional and endocrine disturbances. N Engl J Med 1947; 236:783-793.
288. Widdowson EM. Mental contentment and physical growth. Lancet 1951; 1:1316-1318.
289. Spitz R. Hospitalism, an inquiry into the genesis of psychiatric conditions in early childhood. Psychoanal Study Child 1945; 1:53-74.
290. Spitz R. Hospitalism, a follow-up report. Psychoanal Study Child 1946; 2:113-117.
291. Kerr MA, Black MM, Krishnakumar A. Failure-to-thrive, maltreatment and the behavior and development of 6-year-old children from low-income, urban families: a cumulative risk model. Child Abuse Negl 2000; 24: 587-598.
292. Wu SS, Ma CX, Carter RL, et al. Risk factors for infant maltreatment: a population-based study. Child Abuse Negl 2004; 28:1253-1264.
293. Lounds JJ, Borkowski JG, Whitman TL. The centers for the prevention of child neglect Reliability and validity of the mother-child neglect scale. Child Maltreat 2004; 9:371-381.
294. Dubowitz H, Newton RR, Litrownik AJ, et al. Examination of a conceptual model of child neglect. Child Maltreat 2005; 10:173-189.
295. Allin H, Wathen CN, MacMillan H. Treatment of child neglect: a systematic review. Can J Psychiatry 2005; 50:497-504.
296. Chatoor I. Feeding disorders in infants and toddlers: diagnosis and treatment. Child Adolesc Psychiatr Clin N Am 2002; 11:163-183.
297. Chatoor I, Ganiban J, Hirsch R, Borman-Spurrell E, Mrazek DA. Maternal characteristics and toddler temperament in infantile anorexia. J Am Acad Child Adolesc Psychiatry 2000; 39:743-751.
298. Chatoor I. Infantile anorexia nervosa: a developmental disorder or separation and individuation. J Am Acad Psychoanal 1989; 17:43-64.
299. Fryer GE Jr. The efficacy of hospitalization of non-organic failure to thrive children: a meta-analysis. Child Abuse Neglect 1988; 12:375-381.
300. Casey PH, Wortham B, Nelson JY. Management of children with failure to thrive in a rural ambulatory setting: epidemiology and growth outcomes. Clin Pediatr 1984; 23:325-330.
301. Bithoney WG, McJunkin J, Michalek J, et al. The effect of a multidisciplinary team approach on weight gain in nonorganic failure-to-thrive children. J Dev Behav Pediatr 1991; 12:254-258.
302. World Health Organization. Energy and Protein Requirements. In: Report of a Joint FAO/WHO/UNU Expert Consultation. WHO Technical Report Series No. 724. Geneva: World Health Organization, 1985.
303. Sentongo TA, Tershakovec AM, Mascarenhas MR, Watson MH, Stallings VA. Resting energy expenditure and prediction equations in young children with failure to thrive. J Pediatr 2000; 136:345-350.
304. Ramsay M, Zelaso PR. Food refusal in failure to thrive infants: nasogastric feeding combined with interactivebehavioral treatment. J Pediatr Psychol 1988; 13:329-347.
305. Latham MC, Stephenson LS, Kinoti SN, et al. Improvements in growth following iron supplementation in young Kenyan school children. Nutrition 1990; 6:159-165.
306. Angeles IT, Schultnick WJ, Matulessi P, et al. Decreased rate of stunting among anemic Indonesian preschool children through iron supplementation. Am J Clin Nutr 1993; 58:339-342.
307. Black RE. Therapeutic and preventive effects of zinc on serious childhood infectious diseases in developing countries. Am J Clin Nutr 1998; 68:476S-479S.
308. Sazawal S, Black RE, Jalla S, et al. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind controlled trial. Pediatrics 1998; 102:1-5.
309. Umeta M, West CE, Haidar J, et al. Zinc supplementation and stunted infants in Ethiopia: a randomised controlled trial. Lancet 2000; 355:2021-2026.
310. Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators’ Collaborative Group. J Pediatr 1999; 35:689-697.
311. Rosado JL, Lopez P, Munoz E, et al. Zinc supplementation reduced morbidity, but neither zinc nor iron supplementation affected growth or body composition of Mexican preschoolers. Am J Clin Nutr 1997; 65:13-19.
312. International Research on Infant Supplementation (IRIS) Study Group. Efficacy of a foodlet-based multiple micronutrient supplement for preventing growth faltering, anemia, and micronutrient deficiency of infants: the four country IRIS trial pooled data analysis. J Nutr 2005; 135:631S-638S.
313. Whitehead RG, Biol FL. Protein and energy requirement of young children living in the developing countries allow for catch-up growth after infections. Am J Clin Nutr 1977; 30:1545-1547.
314. Reeds PJ, Jackson AA, Picou D, Poulter N. Muscle mass and composition in malnourished infants and children and changes seen after recovery. Pediatr Res 1978; 12:613-618.
315. Sturm L, Dawson P. Working with families-an overview for providers. In: Kessler DB, Dawson P, eds. Failure to Thrive and Pediatric Undernutrition-A Transdisciplinary Approach. Baltimore: Brookes Publishing Co., 1999:65-76.
316. Rudolf MC, Logan S. What is the long-term outcome for children who fail to thrive? A systematic review. Arch Dis Child 2005; 90:925-931.
317. Oates RK, Peacock A, Forrest D. Long-term effects of nonorganic failure to thrive. Pediatrics 1985; 75:36-40.
318. Singer L. Long-term hospitalization of non-organic failure-to-thrive infants: patient characteristics and hospital course. J Dev Behav Pediatr 1987; 8:25-31.
319. Casey PH. Diagnostic coding of children with failure to thrive. In: Kessler DB, Dawson P, eds. Failure to Thrive and Pediatric Undernutrition-A Transdisciplinary Approach. Baltimore: Brookes Publishing, 1999: 281-286.
320. Hess CA. Managed care as part of family-centered service systems. In: Kessler DB, Dawson P, eds. Failure to Thrive and Pediatric Undernutrition-A Transdisciplinary Approach. Baltimore: Brookes Publishing, 1999: 287-302.
321. Nandy S, Irving M, Gordon D, Subramanian SV, Smith GD. Poverty, child undernutrition and morbidity: new evidence from India. Bull World Health Organ 2005; 83:210-216.
322. Nikens PR. Stature reduction as an adaptive response to food production in Mesoamerica. J Archaeol Sci 1976; 3:21-41.
323. Stin WA. Evolutionary implications of changing nutritional patterns in human populations. Am Anthropol 1971; 73:1019-1030.
324. Lifshitz F. Nutrition and growth. In: Paige DM, ed. Clinical Nutrition. Nutrition and Growth Supplement 4. St Louis: CV Mosby, 1985:40-47.
325. Poulton A. Growth on stimulant medication clarifying the confusion: A review. Arch Dis Child 2005; 90:801-806.
326. MTA Cooperative Group. National Institute of Mental Health Multi-modal treatment study of ADHD followups: changes in effectiveness and growth after the end of treatment. Pediatrics 2004; 113:762-769.
327. Lifshitz F, Tarim O, Smith MM. Nutritional growth retardation. In: Lifshitz F, ed. Pediatric Endocrinology. 3rd ed. New York: Marcel Dekker, 1996:103-120.
328. Keller W, Fillynore CM. Prevalence of protein-energy malnutrition. World Health Stat Q 1983; 36:129-167.
329. Pugliese M, Recker B, Lifshitz F. A survey to determine the prevalence of abnormal growth patterns in adolescence. J Adolesc Health Care 1988; 9:181-187.
330. Lifshitz F, Friedman S, Smith MM, et al. Nutritional dwarfing: a growth abnormality associated with reduced erythrocyte Nap, Kp ATPase activity. Am J Clin Nutr 1991; 54:1-7.
331. Straus DS. Nutritional regulation of visceral markers in rat liver and cultured hepatoma cells. Clin Chem Lab Med 2002; 40:1274-1280.
332. Munoz MT, Argente J. Anorexia nervosa in female adolescents: endocrine and bone mineral density disturbances. Eur J Endocrinol 2002; 147:275-286.
333. Thissen JP, Underwood LE, Ketelslegers JM. Regulation of insulin-like growth factor-I in starvation and injury. Nutr Rev 1999; 57:167-176.
334. Phillips LS, Pao CI, Villafuerte BC. Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. Prog Nucleic Acid Res Mol Biol 1998; 60:195-265.
335. Estivariz CF, Ziegler TR. Nutrition and the insulin-like growth factor system. Endocrine 1997; 7:65-71.
336. Phillips LS, Young HS. Nutrition and somatomedin 1. Effect of fasting and re-feeding on serum somatomedin activity and cartilage growth activity in rats. Endocrinology 1976; 99:304-314.
337. Phillips LS, Orawski AT, Belosky DC. Somatomedin and nutrition IV. Regulation of somatomedin activity and growth cartilage activity by quantity and composition of diet in rats. Endocrinology 1978; 103:121-124.
338. Golden M, Jackson AA. Chronic severe under-nutrition. In: Olson RE, Broquist HP, Chichester CO, Darby WJ, Kolbye AC Jr., Stalvey RM, eds. Present Knowledge in Nutrition. Washington, DC: Nutrition Foundation, 1984:57-67.
339. Byung PY. Update on food restriction and aging. Rev Biol Res Aging 1985; 2:435-443.
340. Patrick J, Golden M. Leukocyte electrolytes and sodium transport in protein energy malnutrition. Am J Clin Nutr 1977; 30:1478-1481.
341. Montage A, Brace C. Human Evolution. 2nd ed. New York: Macmillan, 1977.
342. Beaton GH. The significance of adaptation in the definition of nutrient requirements and for nutrition policy. In: Blaxter KL, Waterlow JC, eds. Nutritional Adaptation in Man. London: Libbey, 1985:219-232.
343. Tarim O, Chasalow FI, Murphy J, Rising R, Carrillo A, Lifshitz F. Evaluation of differential effects of carbohydrate and fat intake on weight gain, serum IGF-1, and erythrocyte NapKp ATPase activity in suboptimal nutrition in rats. J Am Coll Nutr 1997; 16:159-165.
344. Carrillo A, Rising R, Cole C, Tverskaya R, Lifshitz F. Low dosages of exogenous growth hormone and its effects on growth in an animal model of suboptimal nutrition. Nutrition 2000; 16:1074-1078.
345. Carrillo A, Rising R, Tverskaya R, Lifshitz F. Effects of exogenous recombinant human growth hormone on an animal model of suboptimal nutrition. J Am Coll Nutr 1998; 17:276-281.
346. Rising R, Scaglia JF, Cole C, Tverskaya R, Duro D, Lifshitz F. Exogenous recombinant human growth hormone effects during suboptimal energy and zinc intake. Nutr Metab (Lond) 2005; 2:10.
347. Gamba CA, Friedman SM, Rodriquez PN, Macri EV, Vacas MI, Lifshitz F. Metabolic status in growing rats fed isocaloric diets with increased carbohydrate-to-fat ratio. Nutrition 2005; 21:249-254.
348. Ramsey JJ, Hagopian K, Kenny TM, et al. Proton leak and hydrogen peroxide production in liver mitochondria from energy-restricted rats. Am J Physiol Endocrinol Metab 2004; 286:E31-E40.
349. Boyer PM, Friedman SM, Olivera MI, Bozzini C, Norese MF, Rodriguez PN. Bone growth in nonorganic nutritional dwarfing rats. Acta Odontol Latinoam 2000; 13:21-29.
350. Gat YG, Ben AT, Shtaif B, et al. Leptin reverses the inhibitory effect of caloric restriction on longitudinal growth. Endocrinology 2004; 145:343-350.
351. Hosea HJ, Rector ES, Taylor CG. Dietary repletion can replenish reduced T cell subset numbers and lymphoid organ weight in zinc-deficient and energy-restricted rats. Br J Nutr 2004; 91:741-747.
352. Pahlavani MA. Influence of caloric restriction on aging immune system. J Nutr Health Aging 2004; 8:38-47.
353. Poehlman F, Melby CL, Badylak SF. Resting metabolic rate and post-prandial thermogenesis in highly trained and untrained males. Am J Clin Nutr 1988; 47:793-798.
354. Waterlow JC, Golder M, Picou D. Protein turnover in man. Am J Clin Nutr 1977; 30:1333-1339.
355. Read WW, McLaren DS, Tchalian M, Nassar S. Studies with 15N-labeled ammonia and urea in the malnourished child. J Clin Invest 1969; 48:1143-1149.
356. Waterlow JC, Golden MH, Garlick PJ. Protein turnover in man measured with 15N: comparison of end products and dose regimes. Am J Physiol 1978; 235:E165-E174.
357. Golden M, Waterlow JC, Pilou D. The relationship between dietary intake, weight change, nitrogen balance, protein turnover in man. Am J Clin Nutr 1977; 30:1345-1348.
358. Rising R, Lifshitz F. Energy expenditures and physical activity in rats with chronic suboptimal nutrition. Nutr Metab (Lond) 2006:3:11.
359. Klein DC, Moore RY, Reppert SM. Suprachiasmatic Nucleus: The Mind’s Clock. New York: Oxford University Press, 1991.
360. Duffy PH, Leakey JE, Pipkin JL, Turturro A, Hart RW. The physiologic, neurologic, and behavioral effects of caloric restriction related to aging, disease, and environmental factors. Environ Res 1997; 3:242-248.
361. Zhou D, Huether G, Wiltfang J, Hajak G, Ruther E. Serotonin transporters in the rat frontal cortex: lack of circadian rhythmicity but down-regulation by food restriction. J Neurochem 1996; 67:656-661.
362. Roblero AR, Juarez AS, Castaneda JR, Escobar C, Cintra L. Organization of circadian rhythmicity and suprachiasmatic nuclei in malnourished rats. Am J Physiol 1997; 273:R1321-R1333.
363. Rikke BA, Yerg JE, Battaglia ME, Nagy TR, Allison DB, Johnson TE. Strain variation in the response of body temperature to dietary restriction. Mech Ageing Dev 2003; 124:663-678.
364. Rising R, Keys A, Ravussin R, Bogardus A. Concomitant inter-individual variations in body temperature and metabolic rate. Am J Physiol 1992; 263:E730-E734.
365. Yu BP, ed. Modulation of Aging Processes by Dietary Restriction. Boca Roton, FL: CRC Press, 1994.
366. Wanagat J, Allison DB, Weindruch R. Caloric intake and aging: mechanism in rodents and a study in nonhuman primates. Toxicol Sci 1999; 52:S35-S40.
367. Sacher GA, Duffy PH. Genetic relation of life span to metabolic rate for inbred mouse strains and their hybrids. Fed Proc 1979; 38:184-188.
368. WangMC, Bohmann D, Jasper H. JNKextends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 2005; 121:115-125.
369. Viteri FE, Torun B. Nutrition, physical activity and growth. In: Ritzer M, Apsia A, Hall K, eds. The Biology of Normal Human Growth. New York: Raven Press, 1981:269-273.
370. Lifshitz F, Brasel JA. Nutrition in endocrine disease. In: Kappy MS, Blizzard RM, Migeon C, eds. Wilkins Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolecence. Spingfield, IL: Charles C Thomas Pub., 1992:187-205.
371. Dietary Guidelines for Americans 2005, Department of Health and Human Services.
372. Abdenur JE, Publiese MT, Cervantes C, Fort P, Lifshitz F. Alterations in spontaneous growth hormone secretion and the response to GH-releasing hormone in children with non-organic nutritional dwarfing. J Clin Encocrinol Metab 1992; 75:930-934.
373. Alemzadeh R, Pugliese M, Lifshitz F. Disorders of puberty. In: Friedman SB, Fisher M, Shonberg SK, eds. Comprehensive Adolescent Health Care. St. Louis: Quality Medical Publishing, 1992:187-205.
374. Brettler DB, Forsberg A, Bolivar E, et al. Growth failure as a prognostic indicator for progression to acquired immunodeficiency syndrome in children with hemophilia. J Pediatr 1990; 117:584-588.
375. Gertner JM, Kaufman FR, Donfield SM, et al. Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: hemophilia growth and development study. J Pediatr 1994; 124:896-902.
376. Kirschner B. Nutritional consequences of inflamatory bowel disease on growth. J Am Col Nutr 1988; 7:301-308.
377. Wine E, Reif SS, Leshinsky-Silver E, et al. Pediatric Crohn’s disease and growth retardation: the role of genotype, phenotype and disease severity. Pediatrics 2004; 114:1281-1286.
378. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001; 411:599-603.
379. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001; 411:603-606.
380. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet 2001; 357:1925-1928.
381. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70:845-857.
382. Krok KL, Lichtenstein GR. Nutrition in Crohn disease. Curr Opin Gastroenterol 2003; 19:148-153.
383. Kirschner BS, Sutton MM. Somatomedin C levels in growth impaired children and adolescents with chronic inflamtory bowel disease. Gastroenterology 1986; 91: 830-836.
384. Belli DC, Seidman E, Bouthillier L, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn’s disease. Gastrolenterology 1988; 94:603-610.
385. Seidman E, LeLeiko N, Ament M, et al. Nutritional issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991; 12:424-438.
386. Lindor KD, Fleming CR, Burnes JU, et al. A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn’s disease. Mayo Clin Proc 1992; 67:328-333.
387. Logan RF, Gillon J, Ferrington C, Ferguson A. Reduction of gastrointestinal protein loss by elemental diet in Crohn’s disease of the small bowel. Gut 1981; 22: 383-387.
388. LaSala MA, Lifshitz F, Silverberg M, et al. Magnesium metabolism studies in children with chronic inflammatory disease of the bowel. J Pediatr Gastroenterol Nutr 1985; 4:75-81.
389. Nishi Y, Lifshitz F, Bayne MA, et al. Zinc status and its relation to growth retardation in children with chronic inflammatory bowel disease. Am J Clin Nutr 1980; 33:2613-2621.
390. Griffin IJ, Kim SC, Hicks PD, et al. Zinc metabolism in adolescents with Crohn’s disease. Pediatr Res 2004; 56:235-239.
391. Morin CL, Roulet M, RoyCC, Weber A.Continuous elemental enteral alimentation in childrenwith Crohn’s disease and growth failure. Gastroenterology 1980; 79:1205-1210.
392. Knight C, El-Matary W, Spray C, Sandhu BK. Long-term outcome of nutritional therapy in paediatric Crohn’s disease. Clin Nutr 2005; 24:775-779.
393. Slonim AE, Bulone L, Damore MB, et al. A preliminary study of growth hormone therapy for Crohn’s disease. N Engl J Med 2000; 342:1633-1637.
394. Mauras N, George D, Evans J, et al. Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study. Metabolism 2002; 51:127-135.
395. Groll A, Candy DCA, Preece MA, Tanner JM, Harries JT. Short stature as the primary manifestation of coeliac disease. Lancet 1980; 22:1097-1099.
396. Cacciari E, Salardi S, Volta U, et al. Can antigliadin antibody detect symptomless coeliac disease in children with short stature? Lancet 1985; 1:1469-1471.
397. Rosenbach Y, Dinari G, Zahavi I, Nitzan M. Short stature as the major manifestation of celiac disease in older children. Clin Pediatr (Phila) 1986; 25:13-16.
398. Stenhammar L, Fallstrom SP, Jansson G, et al. Coeliac disease in children of short stature without gastrointestinal symptoms. Eur J Pediatr 1986; 2145:185-186.
399. Rossi TM, Albini CH, Kumar V. Incidence of celiac disease identified by the presence of serum endomysial antibodies in children with chronic diarrhea, short stature, or insulin-dependent diabetes mellitus. J Pediatr 1993; 123:262-264.
400. Carlsson AK, Axelsson IEM, Borulf SK, Bredberg ACA, Ivarsson S-A. Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. Pediatrics 2001; 107:42-45.
401. Hoffenberg EJ, Mackenzie T, Barriga GS, et al. A prospective study of the incidence of celiac disease. J Pediatr 2003; 143:308-314.
402. Hoffenberg EJ, Emery LM, Barriga KJ, et al. Clinical features of children with screening-identified evidence of celiac disease. Pediatrics 2004; 113:1254-1259.
403. Rostom A, Dube C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005; 128(4 suppl 1):S38-S46.
404. Schuppan D, Dennis MD, Kelly CP. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management. Nutr Clin Care 2005; 8:54-69.
405. Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005; 40:1-19.
406. Barker CC, Mitton C, Jevon G, Mock T. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics 2005; 115:1341-1346.
407. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119:234-242.
408. Kemppainenn JA, Svens E, Kirjavainent, et al. Osteoporosis in adults with celiac disease. Bone 1999; 24:249-255.
409. Ferguson A, Kingstone K. Celiac disease and malignancies. Acta Paediatr 1996; 85(suppl 412):78-81.
410. Catassi C, Fabiani E, Ratsch IM, et al. The coeeliac Iceberg in Italy: a multicenter antigliadin screening for coeliac disease in school age subjects. Acta Peadiatr 1996; 85 (412 suppl):29-35.
411. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3:797-801.
412. Sandberg DE, Smith MM, Fornari V, Goldstein M, Lifshitz F. Nutritional dwarfing: is it a consequence of disturbed psychosocial functioning? Pediatrics 1991; 88:926-933.
413. Lifshitz F, Moses N. Nutritional dwarfing-growth, dieting and fear of obesity. J Am Col Nutr 1988; 7:367-376.
414. Lifshitz F. Fear of obesity in childhood. In: Williams C, Kinn SY, eds. Annals of New York Academy of Sciences. New York: Academy of Science Press, 1993:230-236.
415. Kreipe RE. Eating disorders in adolescents. Pediatr Rev 1999; 12:410-421.
416. Neumark-Sztainer D, Hannan P.Weight-related behaviors among adolescent girls and boys: results from a national survey. Arch Pediatr Adol Med 2000; 154:569-577.
417. Abramovitz B, Birch L. Five-year-old girls’ ideas about dieting are predicted by their mothers’ dieting. J Am Diet Assoc 2000; 100:1157-1163.
418. Maynard LM, Galuska DA, Blanck HM, Serdula MK. Maternal perceptions of weight status of children. Pediatrics 2003; 111:1226-1231.
419. Schur E, Sanders M, Steiner H. Body dissatisfaction and dieting in young children. Int J Eat Disord 2000; 27:74-82.
420. Neumark-Sztainer D, Rock CL, Thornquist MD, et al. Weight-control behaviors among adults and adolescents: associations with dietary intake. Prev Med 2000; 5: 381-391.
421. Moses N, Banilvy M, Lifshitz F. Fear of obesity among adolescent girls. Pediatrics 1989; 83:393-398.
422. Field AE, Austin SB, Taylor CB, et al. Relation between dietary change among preadolescents and adolescents. Pediatrics 2003; 112:900-906.
423. Vanderwall JG, Thelen MH. Eating and body image concerning obese and average weight children. Addiction Behav 2000; 25:775-778.
424. Stice E, AgrasW, Hammer L. Risk factors for the emergence of childhood eating disturbances: a five-year prospective study. Int J Eat Disord 1999; 25:375-387.
425. Johnson S, Birch L. Parents’ and children’s adiposity and eating style. Pediatrics 1994:653-661.
426. Hood MY, Moore LL, Sundarajan-Ramamurti A, Singer M, Cupples LA, Ellison RC. Parental eating attitudes and the development of obesity in children. The Framingham Children’s Study. Int J Obes 2000; 24:1319-1325.
427. Storz NS, Greene WI. Body weight, body image and perception of fad diets in adolescent girls. J Nutr Ed 1983; 15:15-18.
428. Killen JD, Taylor CB, Telch MJ, Saylor KE, Maron DJ, Robinson TN. Self-induced vomiting and laxative and diuretic use among teenagers:precursors of the binge-purge syndrome. J Am Med Assoc 1986; 255:1447-1449.
429. Tarim O, Newman TB, Lifshitz F. Cholesterol screening and dietary intervention for prevention of adult-onset cardiovascular disease. In: Lifshitz F, ed. Childhood Nutrition. Boca Raton, FL: CRC Press, 1995:13-20.
430. Kavey RE, Daniels SR, Lauer RM, et al. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. J Pediatr 2003; 142:368-372.
431. Kavey R-EW, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 2003; 107:1562-1566.
432. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24:1601-1610.
433. Gidding SS, Dennison BA, Birch LL, et al. AHA Scientific Statement. Endorsed by the American Academy of Pediatrics. Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association. Circulation 2005; 112:2061-2075.
434. Kaistha A, Deckelbaum RJ, Starc TJ, Couch SC. Overrestriction of dietary fat intake before formal nutritional counseling in children with hyperlipidemia. Arch Pediatr Adol Med 2001; 155:1225-1230.
435. Obarzanek E, Kimm SYS, Barton BA, et al. and on Behalf of the DISC Collaborative Research Group. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the dietary intervention study in children (DISC). Pediatrics 2001; 107:256-264.
436. Obarzanek E, Hunsberger SA, Van Horn L, et al. Safety of a fat-reduced diet: the dietary intervention study in children (DISC). Pediatrics 1997; 100:51-59.
437. Garner DM, Garfunkel PE. The eating attitudes test: an index of the symptoms of anorexia nervosa. Psychol Med 1979; 9:273-279.
438. Dietz WH, Hartung R. Changes in height velocity of obese pre-adolescents during weight reduction. Am J Dis Child 1985; 139:704-708.
439. www.health.gov/dietaryguidelines/dga2005/report/HTML/D2.
440. Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, Iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington D.C.: National Academy Press, 2000.
441. http://www.nal.usda.gov/fnic/etext/000105.htm.
442. Hadi H, Stoltzfus RJ, DibleyMJ, et al.VitaminAsupplementation selectively improves the linear growth of Indonesian preschool children: results from a randomized, controlled trial. Am J Clin Nutr 2000; 71:507-513.
443. Muhilal-Permeisih HD, Idjradinata YR, Muherdiyantiningsih D. Vitamin A-fortified monosodium glutamate and health, growth and survival of children: a controlled field trial. Am J Clin Nutr 1988; 48:1271-1276.
444. Fawzi WW, Herrera MG, Willett WC, et al. Dietary vitamin A intake in relation to child growth. Epidemiology 1997; 8:402-407.
445. Fawzi WW, Herrera MG, Wilett WC, et al. The effect of vitamin A supplementation on the growth of preschool children in the Sudan. Am J Public Health 1997; 87:1359-1362.
446. Rahmathullah L, Underwood BA, Thulasiraj RD, Milton RC. Diarrhea, respiratory infections, and growth are not affected by a weekly low-dose vitamin A supplement: a masked, controlled field trial in children in southern India. Am J Clin Nutr 1991; 54:568-577.
447. Pettifor JM. Rickets and vitamin D deficiency in children and adolescents. Endocrinol Metab Clin North Am 2005; 34:537-553.
448. Allen LH. Malnutrition and human function: a comparison of conclusions from the INCAP and nutrition CRSP studies. J Nutr 1995; 125:S1119-S1126.
449. Lawless JW, Latham MC, Stephenson LS, et al. Iron supplementation improves appetite and growth in anemic Kenyan primary school children. J Nutr 1994; 124:645-654.
450. Beaton G, Ghassemi H. Supplementary feeding programs for young children in developing countries. Am J Clin Nutr 1982; 35:864-916.
451. Prasad AS, Miale A, Farid Z, Sandstead HH, Schulert AR. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypogonadism. J Lab Clin Med 1963; 61:537-549.
452. Prasad AS. Zinc deficiency in women, infants, and children. J Am Coll Nutr 1996; 15:113-120.
453. Hambidge KM, Hambidge C, Jacobs M, Baum JD. Low levels of zinc in hair, anorexia, poor growth, and hypogeusia in children. Pediatr Res 1972; 6:868-874.
454. Nishi Y, Hatano S, Aihara K, et al. Transient partial growth hormone deficiency due to zinc deficiency. J Am Coll Nutr 1989; 8:93-97.
455. Slonim AE, Sadick N, Pugliese M, et al. Clinical response of alopecia, trichorrhexis nodosa, and dry, scaly skin to zinc supplementation. J Pediatr 1992; 121:890-895.
456. Favier AE. Hormonal effects of zinc on growth in children. Biol Trace Elem Res 1992; 32:383-398.
457. Neggers YH, Cutter GR, Acton RT, et al. A positive association between maternal serum zinc concentration and birth weight. Am J Clin Nutr 1990; 51:678-684.
458. Kirksey A, Wachs TD, Yunis F, et al. Relation of maternal zinc nurtiture to pregnancy outcome and infant and infant development in an Egyptian village. Am J Clin Nutr 1994; 60:782-792.
459. Osendarp SJM, van Raaij JMA, Arifeen SE, et al. A randomized, placebo-controlled trial of the effect of zinc supplementation during pregnancy on pregnancy outcome in Bagladeshi urban poor. Am J Clin Nutr 2000; 71:114-119.
460. Michaelsen KF, Samuelson G, Graham TW, Lonnerdal B. Zinc intake, zinc status, and growth in a longitudinal study of healthy Danish infants. Acta Pediatr 1994; 83:1115-1121.
461. Díaz-Gómez MN, Doménech E, Barroso F, Castells S, Cortabarria C, Jiménez A. The effect of zinc supplementation on linear growth, body composition, and growth factors in preterm infants. Pediatrics 2003; 111:1002-1009.
462. Kaji M, Gotoh M, Takagi Y, et al. Studies to determine the usefulness of the zinc clearance test to diagnose marginal zinc deficiency and the effects of oral zinc supplementation for short children. J Am Coll Nutr 1998; 17:388-391.
463. Nakamura T, Nishiyama S, Futagoishi-Suginohara Y, et al. Mild to moderate zinc deficiency in short children: effect of zinc supplementation on linear growth velocity. J Pediatr 1993; 123:65-69.
464. Brown KH, Peerson JM, Rivera J, Allen LH. Effect of supplemental zinc on the growth and serumzinc concentrations of prepubertal children: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2002; 75:1062-1071.
465. Nishi Y. Zinc and growth. J Am Coll Nutr 1996; 15:340-344.
466. Ninh NX, Thissen JP, Maiter D, et al. Reduced liver insulin-like growth factor-I gene expression in young zincdeprived rats is associated with a decrease in liver growth hormone (GH) receptors and serum GH-binding protein. J Endocrinol 1995; 144:449-456.
467. Baumann G, Frank SJ. Metalloproteinases and the modulation of GH signaling. J Endocrinol 2002; 174:361-368.
468. Haase H, Maret W. Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in sulin/insulin-like growth factor-I signaling. Expt Cell Res 2003; 291:289-298.
469. Siklar Z, Tuna C, Dallar Y, Tanyer G. Zinc deficiency: a contributing factor of short stature in growth hormone deficient children. J Trop Pediatr 2003; 49:187-188.
470. Yamaguchi M. Role of zinc in bone formation and bone resorption. J Trace Elem Exp Med 1998; 11:119-135.
471. Yamaguchi M, Inamoto K. Differential effects of calciumregulating sulfate hormones on bone metabolism on weanling rats orally administered zinc sulfate. Metabolism 1986; 35:1044-1047.
472. McDonell DP, Mongelsdorf DJ, Pike JW, et al. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 1987; 235:1214-1217.
473. Rosado JL. Separate and joint effects of micronutrient deficiencies on linear growth. J Nutr 1999; 129:S531-S533.
474. Hambidge MK. Zinc deficiency in young children. Am J Clin Nutr 1997; 65:160-161.
475. MaghnieM, Ghirardello S, Genovese E.Magnetic resonance imaging of the hypothalamus-pituitary unit in children suspected of hypopituitarism: who, how, and when to investigate. J Endocrinol Invest 2004; 27:496-509.
476. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000; 85:3990-3993.
477. Moshang T, Grimberg A. Neuroendocrine disorders in children. In: McMillan JA, DeAngelis CD, Feigin RD, Warshaw JB, eds. Oski’s Pediatrics:Principles Practice. 3rd ed. Philadelphia: Lippincott-Williams and Wilkins, 1999:1787-1793.
478. Ranke MB. Diagnosis of growth hormone deficiency and growth hormone stimulation tests. In: Ranke MB, ed. Diagnostics of Endocrine Function in Children and Adolescents. 3rd ed. Basel: Karger, 2003:107-128.
479. Guidelines for the use of growth hormone in children with short stature. A report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr 1995; 127:857-867.
480. Badaru A, Wilson DM. Alternatives to growth hormone stimulation testing in children. Trends Endocrinol Metab 2004; 15:252-258.